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Introduction: Supraventricular tachycardia (SVT) has not been well-described in 3 
cats. The aim of this study was to describe the signalment, clinical findings and 4 
outcome for cats with SVT versus cats with atrial fibrillation (AF). 5 
 6 
Animals: Forty-four client-owned cats; 23 cats with SVT and 21 with AF 7 
 8 
Methods: Retrospective study. Clinical characteristics were compared between 9 
groups using a two-sample t-test or Mann-Whitney U test. Kaplan-Meier survival 10 
curves were generated to assess for impact of rhythm diagnosis, presence of 11 
ventricular arrhythmia, left atrial diameter, heart rate (HR) and congestive heart 12 
failure (CHF) status on cardiac death. Differences in survival between groups were 13 
compared using Mantel-Cox logrank comparison of Kaplan-Meier survival curves. 14 
 15 
Results: Cats with supraventricular arrhythmias most commonly presented with 16 
respiratory distress (10 of 44 cats). Cats with AF had a slower median HR (220 17 
[range 180-260 beats per minute (bpm)] compared to cats with SVT (300 [range 150-18 
380] bpm, p<0.001). All cats with AF had structural heart disease whereas 4 cats 19 
with SVT had no structural abnormalities. Left atrial diameter was significantly larger 20 
in cats with AF (23.7(16.2-40.1) mm, compared to 19.1 (12.8-31.4) mm in SVT cats; 21 
p=0.02)). Median survival was 58 days [1–780] in cats with AF, and 259 days (2 - 22 
2295] in cats with SVT (p=0.1). Cats with signs of CHF had a shorter survival time 23 
(p=0.001). 24 
 3
Conclusions: Most cats with AF or SVT have advanced structural heart disease. 25 
Some cats with SVT had structurally normal hearts, suggesting that SVT in cats is 26 









AF atrial fibrillation 
ATE arterial thromboembolism 
CHF congestive heart failure 
LA left atrium 
LAD left atrial diameter 
LAE left atrial enlargement 
LV FS% left ventricular fractional shortening 
LVID left ventricular internal diameter 
SCD sudden cardiac death 
SVT supraventricular tachycardia 







Supraventricular tachycardia can be defined as any rapid rhythm originating from the 3 
SA node, atrial myocardium, atrioventricular node/junction, or great vessels 4 
connecting to the atria (venae cavae, pulmonary veins, coronary vein) [1]. The 5 
arrhythmia may arise due to spontaneous depolarisation of cardiac cells as a result 6 
of enhanced normal automaticity, abnormal automaticity or triggered electrical 7 
activity [1,2], or due to the formation of macro or micro re-entry circuits. Atrial 8 
fibrillation (AF) is a specific supraventricular arrhythmia in which a series of multiple 9 
microreentrant circuits form within the atria, resulting in a chaotic ventricular rhythm 10 
associated with the random selection of impulses that are conducted via the 11 
atrioventricular node to the ventricles [2,3]. Other supraventricular arrhythmias may 12 
be regular or irregular, depending on how the causal supraventricular impulses are 13 
conducted through the atrioventricular node.  14 
 15 
Whilst there are many studies describing the natural history, treatment and 16 
prognostic significance of SVT and AF in people, our knowledge in cats is based 17 
solely on individual case reports [4–8] and a single retrospective study of 50 cats 18 
with AF [9]. In people [10] and large breed dogs [11,12], AF may occur in the 19 
absence of structural heart disease (known as ‘lone AF’). The latter is associated 20 
with reduced morbidity and mortality, compared to individuals with structural heart 21 
disease [11,13,14].  Lone AF appears to be rare in cats [5]. There is a positive 22 
association of AF with increases in atrial mass [15], and the majority of cats with AF 23 




male, consistent with the reported male predominance in feline cardiomyopathy 25 
[9,16].  26 
The aim of this study was to describe the signalment, presenting complaints, cardiac 27 
phenotype and survival time in cats with SVT and AF. It was hypothesized that the 28 
prognosis of cats with AF would be worse than that of cats with SVT, and cats with 29 
AF would have a larger left atrium. 30 
Animals, materials and methods 31 
Retrospective study 32 
Medical records from the Royal Veterinary College’s Queen Mother Hospital for 33 
Animals’ database were searched for cats examined between November 2004 and 34 
April 2014 using the key terms 'atrial fibrillation feline', 'AF feline', 'supraventricular 35 
tachycardia feline', and 'SVT feline'. Cats were included in the study if both an ECG 36 
recorded at 50mm/s at the date of diagnosis and an echocardiographic examination 37 
performed within 48 hours of the ECG recording were available for review. Cats 38 
without an ECG showing at least 2 leads were excluded. Information was collected 39 
on patient signalment, presenting signs, radiographic, ECG and echocardiographic 40 
findings, therapy and survival status.  41 
 42 
All ECG traces from the date of examination were reviewed by a single board-43 
certified cardiologist in order to confirm the presence of SVT or AF. For the purpose 44 
of this study, the average QRS depolarization rate over 3 seconds (the ventricular 45 
response rate) was referred to as heart rate (HR) and was measured from all ECGs. 46 
All of the cats had over 3 seconds of sustained SVT in the ECG recordings available 47 
for review for calculation of the average rate. To be classified as SVT, the rhythm 48 




1. Criterion 1 for SVT: The presence of a sustained, narrow complex tachycardia 50 
lasting the entire duration of the stored ECG recording, with a regular R-R 51 
interval and HR greater than 260 bpm (Figure Ia supplementary data). 52 
2. Criterion 2 for SVT: Demonstration of an abrupt onset or exit from a narrow 53 
complex tachycardia, either on the paper ECG recording or on subsequent 54 
telemetry (Figure Ib supplementary data). 55 
3. Criterion 3 for SVT: Evidence of a persistent atrial depolarization at a rate 56 
greater than 260 bpm, with or without variable atrioventricular conduction ratio 57 
(Figure Ic supplementary data). 58 
4. Criterion 4 for SVT: A wide complex tachycardia in which an intraventricular 59 
conduction disturbance was suspected, either due to the presence of a 60 
consistent atrioventricular relationship (i.e. a constant P-R interval could be 61 
identified) or in which QRS morphology was identical during sinus rhythm to 62 
the complex morphology documented during the tachycardia (Figure Id 63 
supplementary data). 64 
For the purpose of this study, “SVT” refers to all types of supraventricular 65 
arrhythmias, excluding AF [1]. 66 
Atrial fibrillation was diagnosed when there was a clear absence of P waves in all 67 
recorded leads in association with a variable R-R interval or excluded in cats where 68 
P waves could be visualized [9]. 69 
The ECG traces were also reviewed for the presence of ventricular tachyarrhythmia. 70 
An ectopic complex was classified as ventricular in origin and premature if 1) the 71 
QRS complex was wide (>40ms) and bizarre with a large T wave with opposite 72 
polarity to the QRS complex, and 2) if they occurred prematurely when compared to 73 




with presumed intraventricular conduction disturbance were differentiated from true 75 
ventricular tachycardia have been outlined in the SVT rhythm criteria above.  76 
All echocardiographic measurements were performed by a single board-certified 77 
cardiologist from stored two-dimensional images. All echocardiographic studies were 78 
acquired using the same ultrasound machinea and recorded by a board-certified 79 
cardiologist or supervised cardiology resident. Images were reviewed using a 80 
commercial analysis platformb. Each measured variable was calculated as an 81 
average of at least 3 and 5 different cardiac cycles for cats with SVT and AF 82 
respectively. A leading edge-to-leading edge technique was used to measure left 83 
ventricular (LV) wall thickness (septal and LV free wall) from the long and short-axis 84 
right parasternal 2-dimensional echocardiographic views at the level of the papillary 85 
muscles [18]. The LV wall measurements were obtained at end-diastole, defined as 86 
the first frame after mitral valve closure on the long-axis, or the frame at which left 87 
ventricular internal diameter (LVID) was greatest for short-axis views [19]. The 88 
maximal LV wall thickness was recorded as the highest value from averaged 89 
measures of the interventricular septum (IVS) and LV free wall measurements. 90 
Values ≥6mm were defined as left ventricular hypertrophy [18]. Two-dimensional 91 
measures of cardiac chamber internal dimensions were made using an inner edge-92 
to-inner edge technique, at the boundary between the endocardial surface and blood 93 
pool [18]. End-diastolic LVID was measured from both long and short axis views. Left 94 
ventricular fractional shortening (LV FS%) was measured from M-Mode images 95 
obtained from a right parasternal short-axis view of the LV, obtained at the level of 96 
the papillary muscles. LV FS% was calculated using the following equation: LV FS% 97 
= [LVIDd–LVIDs] /LVIDd (where d=diastole and s=systole) [20]. The LVIDs was 98 




LV systolic dysfunction when LV FS% was ≤30% [19]. Assessment of right-sided 100 
cardiac dimensions was subjective; right atrial dilation was assessed by comparing 101 
right and left atrial areas from the right-parasternal long-axis view [20]. 102 
 103 
Left atrial (LA) size was assessed using two methods: LA diameter to aortic root 104 
diameter ratio (LA:Ao) taken from a two-dimensional image from the right parasternal 105 
short axis view, measured on the first frame after aortic valve closure and LA 106 
diameter (LAD), measured as the diameter of the left atrium parallel to the mitral 107 
annulus at the last frame before mitral valve opening, using a right parasternal 4 108 
chamber long-axis view [21,22]. Left atrial enlargement (LAE) was present when 109 
LA:Ao >1.6 [18] and/or LAD ≥16mm. The presence of spontaneous echo contrast 110 
and/or an intra-cardiac thrombus was recorded. Each cat was assessed for the 111 
presence or absence of congenital cardiac disease, based on the opinion of the 112 
cardiologist reviewing the entire study. 113 
 114 
Thoracic radiographs, when obtained, were evaluated by a board-certified radiologist 115 
at the time of presentation. Congestive heart failure status was determined by the 116 
presence of pulmonary infiltrates consistent with pulmonary edema on thoracic 117 
radiography and/or pleural effusion or pericardial effusion on echocardiography as 118 
determined by a board-certified cardiologist.  119 
 120 
Survival data were obtained from clinical records, or where date or cause of death 121 
was not documented, referring veterinary practices were contacted between August 122 
and December 2014 to establish the outcome of each cat. Cardiac death was 123 




failure (CHF) or arterial thromboembolism (ATE) or died as a result of sudden 125 
cardiac death (SCD). Definitions used for these events were as follows: SCD was 126 
defined as being found dead without an obvious cause at home where the cat had 127 
been apparently well during the preceding 24 hours or as a witnessed event. Death 128 
due to CHF was defined as dying with dyspnea, crackles, cyanosis, fluid pouring out 129 
of the mouth and/or euthanasia due to becoming refractory to CHF medication. 130 
Death due to ATE was defined as death or euthanasia following a new episode of 131 
ATE or worsening of a current ATE episode [23].  132 
Statistical analysis was performed using commercially available softwarec. 133 
Continuous data were assessed for normality using the Shapiro-Wilk test. Normally 134 
distributed data are presented as mean (± standard deviation) and non-normally 135 
distributed data are reported as median [range]. Differences between population 136 
characteristics of cats with SVT vs AF were compared using the two-sample t-test 137 
and Mann-Whitney U test for normally and non-normally distributed data 138 
respectively. Categorical variables were compared using Chi-squared test or 139 
Fischer’s exact test as appropriate.  A statistically significant result was defined as a 140 
p-value <0.05. Kaplan-Meier survival curves were generated to assess for impact of 141 
rhythm diagnosis, presence of ventricular arrhythmia, left atrial size (using LAD), HR 142 
and congestive heart failure status on cardiac death. Differences between groups 143 
were analysed using the Logrank (Mantel-Cox) test. Data was censored if death was 144 
due to unknown or non-cardiac reasons, or if they were still alive at the end of the 145 






One-hundred-and-eight cats were identified from the clinical records database that 149 
had been diagnosed with SVT or AF. Fifty-four cats were excluded due to 150 
unavailability of a recorded ECG for review, while 10 cats were excluded due to 151 
corruption of the stored echocardiographic data, leaving 44 cats that were eligible for 152 
inclusion.  There was no significant difference in sex (p=0.7), age (p=0.1), or breed 153 
(p=0.4) between cats with SVT or cats with AF. The majority (32/44) were male (see 154 
table 1). The breeds represented were domestic short hair (n=29), domestic long 155 
hair (n=5), Maine Coon (n=2), British Shorthair (n=2), Birman (n=2), Persian (n=1), 156 
Ragdoll (n=1), Devon Rex (n=1) and Sphynx (n=1).  157 
 158 
Initial presenting signs were recorded for all 44 cats and are summarized in table 2. 159 
The most frequent presenting signs across both groups were respiratory distress and 160 
lethargy. All cats with AF had clinical signs. Only 2 cats were subclinical on 161 
presentation, both of which had SVT. 162 
 163 
As expected, all cats with AF had a chaotic rhythm on auscultation, compared to 12 164 
cats with SVT (p=0.01), likely due to the presence of sinus rhythm with numerous 165 
supraventricular ectopic complexes, numerous paroxysms of SVT or due to the 166 
presence of SVT with variable atrioventricular conduction at the time of auscultation. 167 
The group of cats with AF had a significantly slower HR documented on their ECG 168 
(220 beats per minute [180-260]) when compared to the group of cats with SVT (300 169 
beats per minute [150-380], p<0.001). 170 
 171 
Thoracic radiographs were available in 27 of the cats (13 cats with AF and 14 cats 172 




7 cats with SVT): 3 cats had pulmonary edema (1 cat with AF, 2 cats with SVT), 12 174 
had pleural effusion (8 cats with AF, 4 cats with SVT) and 3 cats had both pleural 175 
effusion and edema (2 cats with AF and 1 with SVT), with no significant differences 176 
between groups (p=0.1). The presence of pericardial effusion was documented via 177 
ultrasound in 7 cats (1 with SVT and 6 with AF).  178 
 179 
All cats with AF had echocardiographic evidence of left or right atrial enlargement, 180 
whereas 4 cats with SVT had no evidence of underlying cardiac disease. Of the 181 
latter, one cat (an 11-year-old MN DLH) was subsequently diagnosed with splenic 182 
haemangiosarcoma with metastases to both liver and omentum. Another cat (9-year-183 
old MN DSH) had a history of chronic diarrhea and recent onset vomiting of unknown 184 
origin. Investigations revealed no significant biochemical or hematological 185 
abnormalities and urinalysis and abdominal ultrasound were unremarkable. No 186 
identifiable co-morbidities were found in the 2 remaining cats. The ECGs from these 187 
4 cats are available for review as supplementary data online, (Figures II to V). When 188 
cats were classified according to severity of LAE using LAD, 7 cats had mild LAE (5 189 
with SVT, 2 with AF), 15 cats had moderate LAE (7 with SVT and 8 with AF) and 12 190 
cats had severe LAE (5 with SVT and 7 with AF). The following values were used for 191 
mild, moderate and severe LAE respectively; 16-18mm, 18-24mm and >24mm.[20] 192 
Only two cats had congenital heart disease, including a cat with SVT that had left 193 
ventricular hypertrophy, LAE and a ventricular septal defect (VSD) identified 194 
incidentally on echocardiographic examination and a cat with AF that had a double-195 





The proportion of cats with left ventricular hypertrophy was similar between groups 198 
which was documented in 14 cats with AF and 11 with SVT (p=0.2). Subjective right-199 
sided eccentric +/- concentric right ventricular hypertrophy was more commonly 200 
identified in cats with AF (p=0.04), and of the 7 cats with right-sided cardiac changes 201 
(1 cat with SVT and 6 cats with AF), 6 had concurrent LAE. Left ventricular systolic 202 
dysfunction was identified in 8 cats, with equal numbers in both groups.   203 
The majority of cats had LAE (see table 4), the proportion of which was similar 204 
between groups. Cats with AF had larger LAD (23.7mm [16.1-40.1] vs 19.1mm 205 
[12.8-31.4], p=0.02). There was no significant difference in LA:Ao between groups 206 
(p=0.08).  The 4 cats with SVT and no LAE were the same cats detailed previously 207 
as having no evidence of structural cardiac disease. The only cat with AF and no 208 
LAE was the cat with a double-chambered right ventricle, VSD, and severe right 209 
atrial enlargement. Spontaneous echo-contrast was common, identified in 22% of 210 
cats (n=10). Six of these cats also had visible thrombi within the left atrial 211 
appendage.  212 
 213 
Cardiac medications were administered to 43 of the 44 cats. The antiarrhythmic 214 
medications administered were diltiazem (n=15), atenolol (n=10) and sotalol (n=1) 215 
Antiarrhythmic medication was administered more commonly in cats with SVT than 216 
AF (16 cats vs 6 cats respectively, p=0.01). Antithrombotic medication (aspirin 217 
and/or clopidogrel) was administered in 23 cats and 29 cats were treated with 218 
furosemide. 219 
 220 
Survival information was available for 40 cats (21 SVT and 19 AF), and the cause of 221 
death was known for 32 cats (15 SVT and 17 AF). The most common cause of death 222 




cats with SVT (10 cats with AF and 10 cats with SVT). This was followed by ATE 224 
reported in 23% of cats with AF (n=5) and 13% of cats with SVT (n=3). Sudden 225 
cardiac death was reported in 2 cats (1 with AF and 1 with SVT). Median survival 226 
was 58 days [1 – 780] in cats with AF, and 259 days (2 – 2295] in cats with SVT 227 
(Figure 1, p=0.1). Cats with a lower HR did not survive longer until cardiac death 228 
than cats with a higher HR with either tachyarrhythmia, or when the population of 229 
cats was considered as a single group (Figure VI in supplementary data). Increased 230 
LA size (according to median LAD for cats with SVT, AF and all cats) did not predict 231 
worse survival (Figure VII in supplementary data). The presence of congestive heart 232 
failure at presentation was associated with a worse prognosis, (p=0.001, Figure 2) 233 
whilst the presence or absence of ventricular arrhythmia on resting ECG had no 234 
association with cardiac death (Figure VIII in supplementary data). 235 
 236 
Discussion 237 
The causal mechanisms, predisposing factors and natural course of SVT and AF are 238 
well described in people and to a lesser extent in dogs. Cats with SVT and AF have 239 
not been well-represented in the literature, and our study provides information on the 240 
characteristics and outcome in cats with these rhythm disturbances. Cats with AF 241 
are generally recognised as having a poor prognosis [9], so we have provided similar 242 
information in a contemporary cohort of cats with SVT as a comparison. This is the 243 
largest study to describe cats with SVT. 244 
 245 
The signalment of this population was reflective of the high prevalence of 246 
cardiomyopathy, demonstrating that cats presenting with SVT or AF have a male 247 




presenting sign across both groups was respiratory distress, most likely a sign of 249 
congestive heart failure, which is in agreement with previously published studies 250 
demonstrating that the primary presenting sign of cats with AF is decompensated 251 
cardiac disease [9]. 252 
The contribution and relevance of arrhythmia-induced remodeling to cardiac disease 253 
progression is poorly understood in cats. In dogs, SVT appears to be frequently 254 
associated with structural heart disease (65% of cases in one study) [25]. It is still not 255 
clear whether the structural changes seen in these cats are a consequence of pre-256 
existing myocardial disease or due to the presence of chronic arrhythmias resulting 257 
in cardiac remodeling. Information regarding thyroid status and blood pressure were 258 
inconsistently recorded and therefore secondary cardiomyopathy could not be 259 
excluded in these cats. Hyperthyroidism is a known risk factor for the development of 260 
atrial fibrillation and supraventricular tachycardias in people (prevalence varies from 261 
2-20%) [26]. In people, achievement of a euthyroid state is typically associated with 262 
restoration of sinus rhythm, especially in young patients and where duration of 263 
disease is not long [26]. Thyroid status was variably determined in our population of 264 
cats. Consequently, any association between hyperthyroidism and the presence of 265 
supraventricular arrhythmias could not be assessed and is considered a limitation of 266 
the study.  267 
Left atrial diameter was used to assess LA size (in addition to LA:Ao) and was 268 
significantly larger in cats with AF than cats with SVT. A critical mass of atrial tissue 269 
is required to sustain the minimal number of circuits necessary to perpetuate AF [15], 270 
and consequently, this arrhythmia is frequently associated with conditions (e.g., 271 




dilation. This finding is also reported in the Côté et al. (2004) study that identified 273 
LAE in cats with concurrent AF [9]. Left atrial enlargement is associated with a poor 274 
prognosis in cats with acquired heart disease, and consequently, AF has been 275 
considered an end-stage event in cats with myocardial disease [27]. Left atrial size 276 
did not have an impact on overall survival in our study. This may be due to the small 277 
numbers of cats included in this population, as a larger study demonstrated a 278 
measurable effect of LA size on outcome [16]. There is one report of lone AF in a cat 279 
[5]. One cat with AF had normal LA size in our study, but in this cat, development of 280 
AF was attributed to severe right atrial enlargement (the cat had a double-281 
chambered right ventricle and VSD). 282 
The majority of cats with right-sided remodelling also had LAE. These changes could 283 
represent primary bilateral ventricular pathology (e.g. hypertrophic cardiomyopathy 284 
or arrhythmogenic right ventricular cardiomyopathy affecting both ventricles), or 285 
might reflect remodelling consistent with a tachycardia-induced cardiomyopathy. 286 
Tachycardia-induced remodeling is a well-established pathological sequela to rapid-287 
pacing in experimental models of cardiac failure in dogs and has also been 288 
documented secondary to naturally-acquired tachyarrhythmia in dogs [28]. Sustained 289 
tachycardia or paroxysms of any type of tachyarrhythmia affecting more than 15% of 290 
the daily heart beats may result in tachycardia-induced cardiomyopathy in people 291 
[29–31]. A single case report exists describing feline tachycardia-induced 292 
cardiomyopathy [5], in which follow-up longitudinal echocardiographic assessment 293 
showed progressive reduction in cardiac size in response to oral antiarrhythmic 294 
therapy. Unfortunately, few cats in this study had echocardiographic assessment 295 
prior to onset of the arrhythmia, longitudinal echocardiographic follow up and/or 296 




The data presented here show that SVT can be documented in cats without 298 
structural heart disease. In 2 of the 4 cats with no evidence of heart disease, 299 
concurrent systemic disease was also documented (metastatic splenic 300 
hemangiosarcoma, and chronic gastrointestinal disease of unknown origin 301 
respectively.) Gastrointestinal signs are frequently reported in dogs with SVT [25], 302 
however, it is not possible for us establish whether there is any link between the 303 
rhythm disturbances in these cats and their concurrent systemic signs. Two cats 304 
presented with paroxysmal supraventricular tachycardia and had no known co-305 
morbidities, though further characterisation of the SVT could not be achieved. A 306 
potential mechanism for SVT in a young animal without structural heart disease is 307 
macroreentrant tachycardia involving an accessory pathway, but the 308 
electrocardiographic features for this condition have not been well described in cats. 309 
Ventricular pre-excitation was not identified in any cat in this study and the current 310 
practical limitations in performing diagnostic electrophysiological studies makes it 311 
challenging to achieve a definitive diagnosis in cats with SVT [3].  312 
The median HR obtained from the ECG recordings was found to be higher in cats 313 
with SVT than AF (300 bpm and 220 bpm respectively), which is perhaps 314 
unsurprising given the diagnostic criteria for this study for cats with SVT (i.e. the 315 
presence of an sustained narrow complex tachycardia, with a regular R-R interval 316 
and HR greater than 260 bpm). The median HR of 220 bpm in cats with AF was 317 
similar to the rate that was published from a larger group of cats with this arrhythmia 318 
[9]. It is interesting to note that medications aimed at reducing HR were uncommonly 319 
prescribed to cats with AF in this population despite the fact that control of average 320 
HR is considered to be an important therapeutic target in both people and dogs. It is 321 




‘treated’ cats had an influence on survival due to inconsistencies in treatment 323 
recording in relation to ECG traces in the hospital and lack of subsequent re-324 
examinations following the introduction of treatment. Recently published 325 
retrospective data in dogs has suggested that a lower average HR in dogs with AF is 326 
associated with improved survival [32] and it is not known whether the same would 327 
be true in cats. This study did not document a statistically significant association 328 
between HR and survival in cats with AF or SVT, or when the population was 329 
considered as a whole, although it is possible that this study was under-powered to 330 
achieve statistical significance. Furthermore, the impact of medication on survival 331 
remains unknown due to incomplete information available from the clinical records; 332 
specifically, regarding the timing of medication administration in relation to 333 
acquisition of the recorded ECG traces, doses of medications, lack of 24-hour Holter 334 
ECG analysis and infrequency of re-examination following the introduction of 335 
treatment. 336 
 337 
In this group of cats, the documentation of transient ventricular arrhythmia on 6-lead 338 
paper trace ECGs was not associated with worse survival.  In recent studies 339 
evaluating clinical risk markers for HCM in people, non-sustained ventricular 340 
tachycardia proved to be a significant independent risk factor for SCD, especially in 341 
the young [33]. We know from previous studies that cats with myocardial disease 342 
have more frequent and complex ventricular arrhythmia than normal cats [34], 343 
however further research, ideally with Holter ECG data and a larger number of cats, 344 
would be required to determine whether these arrhythmias are associated with 345 




There were many limitations of this study, some of which relate to the inherent 347 
challenges associated with the recording and interpretation of feline ECGs, including 348 
low amplitude voltages, and motion/purring artifacts. At a HR > 260 bpm, short R-R 349 
intervals can make it challenging to differentiate truly irregular rhythms from regular 350 
rhythms [9], and some of the ECGs may have been incorrectly classified. In 351 
particular, small p’ (supraventricular depolarizations not arising from the sinoatrial 352 
node) wave amplitudes made further classification of the SVT impossible in many 353 
cases and so was not attempted in this current study. In some cases, irregular SVT 354 
(e.g. due to multifocal atrial tachycardias or atrial flutter) may have been 355 
misclassified as AF due to an inability to identify p’ or flutter waves. Furthermore, 356 
criteria to define SVT were extrapolated from those used in dogs due to lack of well-357 
established criteria in cats. An arbitrary rate of 260 bpm was used to define SVT; 358 
however, it is possible that some of these cats may have had a physiological sinus 359 
tachycardia. Conversely, some cats with a true SVT but a HR less than 260 bpm 360 
may have been mistakenly excluded. Comparing cats with SVT to those with AF 361 
carries with it a number of inherent limitations. Atrial fibrillation was presumed to be 362 
sustained in all cats presenting with this arrhythmia. Holter ECGs were not 363 
performed in any cat and therefore the frequency and duration of SVT is unknown. 364 
Consequently, it is challenging for us to draw conclusions regarding the impact of 365 
this arrhythmia on myocardial remodeling and possible CHF, for example, and 366 
comparing survival data without Holter data therefore may be inappropriate. 367 
Identification of ventricular arrhythmia from a 6-lead paper trace ECG is inferior to 368 
Holter ECG assessment, and therefore underreporting of ventricular arrhythmia is 369 
likely to be present in this group of cats. Further studies regarding the prognostic 370 




are warranted as this may provide additional information with regards to optimizing 372 
therapy. Thoracic radiographs were not performed in all cats and therefore some 373 
cats may have been misclassified regarding their CHF status. 374 
 375 
Almost half of the cats diagnosed with SVT or AF according to the clinical records 376 
system had to be excluded due to missing ECG records from the patient file. A 377 
further 10 cats were removed as the storage discs containing the echocardiographic 378 
images had become corrupted. This could affect the application of findings from this 379 
study to a wider population of cats and importantly the small group sizes may have 380 
limited the statistical power of the analyses. Further studies involving a larger 381 
number of cats are therefore warranted.  382 
 383 
Conclusions 384 
Supraventricular tachycardia was as common as AF in our hospital population, 385 
despite the paucity of case reports in the literature. All cats with AF had underlying 386 
structural heart disease, whereas some cats with SVT had normal cardiac chamber 387 
dimensions. 388 
 389 
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Figure 1.  522 
Kaplan-Meier curves to explore the difference in median survival time between cats 523 




Figure 2.  528 
Kaplan-Meier curves to explore the difference in median survival time between cats 529 










Male 16 16 0.7 
Pedigree 4 6 0.7 
Median age 
(months) 
121 (40-174) 84 (6-196) 0.1 
Median HR (bpm) 
established from 
paper trace ECG 




Table 1. Demographic data for cats with supraventricular tachycardia (SVT) and 





















































No clinical signs 0 (0.0%) 2 (4.5%) 0.5 
Respiratory 
distress 
6 (13.6%) 4 (9.1%) 0.5 
Lethargy 6 (13.6%) 3 (6.8%) 0.3 
Collapse 2 (4.5%) 6 (13.6%) 0.2 
Hindlimb paresis 3 (6.8 %) 2 (4.5%) 0.7 
Ascites 2 (4.5%) 1 (2.3%) 0.6 
Weight loss 1 (2.3%) 2 (4.5%) >0.9 
Cough 1 (2.3%) 0 (0.0%) 0.5 
Inappetence 0 (0.0%) 1 (2.3%) >0.9 
Vomiting 0 (0.0%) 1 (2.3%) >0.9 
Weakness 0 (0.0%) 1 (2.3%) >0.9 
 
Table 2. Presenting signs of cats with supraventricular tachycardia (SVT) and atrial 




































Normal heart 0 4 0.1 
Congenital disease 1 1 >0.9 
LVH 14 11 0.2 
LAE 20 19 0.1 
SEC/thrombus 5 5 >0.9 
Right heart 
disease 
6 1 0.04 
Systolic 
dysfunction 
4 4 >0.9 
 
 
Table 3. Cats with supraventricular tachycardia (SVT) and atrial fibrillation (AF) 
grouped according to phenotypic findings on echocardiography. LAE: left atrial 
enlargement (LA:Ao >1.6 and/or LAD>16mm); LVH: left ventricular hypertrophy; 
































Variable AF SVT p-value 
LVPWDd LAX 
(mm) 
7.1 (3.6-10.5) 5.35 (3.9-
12.1) 
0.2 
IVSd SAX (mm) 5.55 (3.1-8.4) 5 (3.7-8.5) 0.1 
IVSd LAX (mm) 6 (3.9-9.0) 5.3 (4.1-9.9) 0.6 
LVPWd SAX (mm) 6.16 +- 0.49 6.1 +- 0.40 0.9 
LVID LAX (mm) 15.79 +- 0.72 14.98 +- 0.87 0.5 
LA/Ao ratio 2.63 +- 0.16 2.22 +- 0.15 0.08 





FS % 37.29 +- 4.92 38.88 +- 3.88 0.8 
 
Table 4. Specific echocardiographic measures of left ventricular wall thickness, left 
atrial size and systolic function. FS%: fractional shortening; IVSd SAX: 
Interventricular septum in diastole, short-axis; LA/Ao: left atrial to aortic ratio; LVID 
LAX: left ventricular internal diameter, long-axis; LVPWDd LAX: left ventricular 
posterior wall diameter in diastole, long-axis; LVPWd SAX: left ventricular posterior 
wall diameter in diastole, short-axis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
